Resistance to Lyme disease in decorin-deficient mice.

PubWeight™: 1.46‹?› | Rank: Top 5%

🔗 View Article (PMC 199574)

Published in J Clin Invest on April 01, 2001

Authors

E L Brown1, R M Wooten, B J Johnson, R V Iozzo, A Smith, M C Dolan, B P Guo, J J Weis, M Höök

Author Affiliations

1: The Center for Extracellular Matrix Biology, Texas A&M University System Health Science Center, Albert B. Alkek Institute of Biosciences and Technology, Houston, Texas 77030, USA. ebrown@ibt.tamu.edu

Articles citing this

Diagnosis of lyme borreliosis. Clin Microbiol Rev (2005) 4.48

Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes. Nat Rev Microbiol (2012) 3.52

Molecular adaptation of Borrelia burgdorferi in the murine host. J Exp Med (2002) 2.49

The role of decorin in collagen fibrillogenesis and skin homeostasis. Glycoconj J (2003) 2.13

Proteoglycan form and function: A comprehensive nomenclature of proteoglycans. Matrix Biol (2015) 1.91

Both decorin-binding proteins A and B are critical for the overall virulence of Borrelia burgdorferi. Infect Immun (2008) 1.67

The Staphylococcus aureus Map protein is an immunomodulator that interferes with T cell-mediated responses. J Clin Invest (2002) 1.63

Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect Immun (2006) 1.55

Borrelia burgdorferi lacking BBK32, a fibronectin-binding protein, retains full pathogenicity. Infect Immun (2006) 1.52

Assessment of decorin-binding protein A to the infectivity of Borrelia burgdorferi in the murine models of needle and tick infection. BMC Microbiol (2008) 1.51

Decorin-binding proteins A and B confer distinct mammalian cell type-specific attachment by Borrelia burgdorferi, the Lyme disease spirochete. Proc Natl Acad Sci U S A (2003) 1.50

Targeted mutation of the outer membrane protein P66 disrupts attachment of the Lyme disease agent, Borrelia burgdorferi, to integrin alphavbeta3. Proc Natl Acad Sci U S A (2003) 1.50

Borrelia burgdorferi lacking DbpBA exhibits an early survival defect during experimental infection. Infect Immun (2008) 1.36

The regulatory roles of small leucine-rich proteoglycans in extracellular matrix assembly. FEBS J (2013) 1.33

Decorin antagonizes Met receptor activity and down-regulates {beta}-catenin and Myc levels. J Biol Chem (2010) 1.32

Association of linear plasmid 28-1 with an arthritic phenotype of Borrelia burgdorferi. Infect Immun (2005) 1.30

Protective niche for Borrelia burgdorferi to evade humoral immunity. Am J Pathol (2004) 1.29

Decorin antagonizes the angiogenic network: concurrent inhibition of Met, hypoxia inducible factor 1α, vascular endothelial growth factor A, and induction of thrombospondin-1 and TIMP3. J Biol Chem (2011) 1.20

Borrelia burgdorferi adhesins identified using in vivo phage display. Mol Microbiol (2007) 1.17

The role of Borrelia burgdorferi outer surface proteins. FEMS Immunol Med Microbiol (2012) 1.16

Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices. Infect Immun (2004) 1.10

Decorin protein core affects the global gene expression profile of the tumor microenvironment in a triple-negative orthotopic breast carcinoma xenograft model. PLoS One (2012) 1.09

Illuminating the roles of the Borrelia burgdorferi adhesins. Trends Microbiol (2013) 1.03

Common and unique contributions of decorin-binding proteins A and B to the overall virulence of Borrelia burgdorferi. PLoS One (2008) 0.99

Increasing the interaction of Borrelia burgdorferi with decorin significantly reduces the 50 percent infectious dose and severely impairs dissemination. Infect Immun (2007) 0.99

Proteoglycans in host-pathogen interactions: molecular mechanisms and therapeutic implications. Expert Rev Mol Med (2010) 0.96

Lyme arthritis: current concepts and a change in paradigm. Clin Vaccine Immunol (2007) 0.94

Insights into the key roles of proteoglycans in breast cancer biology and translational medicine. Biochim Biophys Acta (2015) 0.92

That's my story, and I'm sticking to it--an update on B. burgdorferi adhesins. Front Cell Infect Microbiol (2014) 0.91

Biological functions of iduronic acid in chondroitin/dermatan sulfate. FEBS J (2013) 0.91

Decorin binding by DbpA and B of Borrelia garinii, Borrelia afzelii, and Borrelia burgdorferi sensu Stricto. J Infect Dis (2011) 0.89

Strain-specific variation of the decorin-binding adhesin DbpA influences the tissue tropism of the lyme disease spirochete. PLoS Pathog (2014) 0.87

Identification of lysine residues in the Borrelia burgdorferi DbpA adhesin required for murine infection. Infect Immun (2014) 0.86

Analysis of Borrelia burgdorferi Surface Proteins as Determinants in Establishing Host Cell Interactions. Front Microbiol (2011) 0.86

An effective second-generation outer surface protein A-derived Lyme vaccine that eliminates a potentially autoreactive T cell epitope. Proc Natl Acad Sci U S A (2004) 0.84

Solution structure of decorin-binding protein A from Borrelia burgdorferi. Biochemistry (2012) 0.84

Analysis of the dbpBA upstream regulatory region controlled by RpoS in Borrelia burgdorferi. J Bacteriol (2010) 0.83

The novel heparin-binding motif in decorin-binding protein A from strain B31 of Borrelia burgdorferi explains the higher binding affinity. Biochemistry (2013) 0.82

Chlamydia muridarum infection associated host MicroRNAs in the murine genital tract and contribution to generation of host immune response. Am J Reprod Immunol (2014) 0.81

Borrelia burgdorferi Keeps Moving and Carries on: A Review of Borrelial Dissemination and Invasion. Front Immunol (2017) 0.80

Decorin binding proteins of Borrelia burgdorferi promote arthritis development and joint specific post-treatment DNA persistence in mice. PLoS One (2015) 0.78

Damage of collagen and elastic fibres by borrelia burgdorferi - known and new clinical and histopathological aspects. Open Neurol J (2012) 0.77

Glycosaminoglycans and infection. Front Biosci (Landmark Ed) (2016) 0.77

RNA-Seq-based analysis of changes in Borrelia burgdorferi gene expression linked to pathogenicity. Parasit Vectors (2015) 0.75

Lyme disease: aetiopathogenesis, factors for disease development and control. Inflammopharmacology (2012) 0.75

Articles cited by this

Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med (1985) 20.49

Lyme disease. N Engl J Med (1989) 14.06

MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol (1994) 7.14

Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol (1997) 6.42

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group. N Engl J Med (1998) 6.18

Lyme borreliosis in selected strains and ages of laboratory mice. J Infect Dis (1990) 5.95

Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem (1998) 4.86

Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc Natl Acad Sci U S A (2000) 4.81

Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun (1995) 2.96

Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol (1998) 2.85

Interaction between Borrelia burgdorferi and endothelium in vitro. J Clin Invest (1990) 2.80

Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71

Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol (1998) 2.68

The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun (1994) 2.44

Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39

Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem (1999) 2.38

Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A (1993) 2.36

Treatment of Lyme arthritis. Arthritis Rheum (1994) 2.27

Successful parenteral penicillin therapy of established Lyme arthritis. N Engl J Med (1985) 2.23

Standard system for infecting ticks (Acari: Ixodidae) with the Lyme disease spirochete, Borrelia burgdorferi. J Med Entomol (1993) 2.19

The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol (1997) 2.18

Distinct characteristics of resistance to Borrelia burgdorferi-induced arthritis in C57BL/6N mice. Infect Immun (1998) 2.12

Dual role of interleukin-10 in murine Lyme disease: regulation of arthritis severity and host defense. Infect Immun (1999) 1.91

Lyme borreliosis: host responses to Borrelia burgdorferi. Microbiol Rev (1991) 1.87

Borrelia burgdorferi bind to epithelial cell proteoglycans. J Clin Invest (1994) 1.86

Use of adhesion-defective mutants of Staphylococcus aureus to define the role of specific plasma proteins in promoting bacterial adhesion to canine arteriovenous shunts. Infect Immun (1995) 1.85

Characterization of a candidate Borrelia burgdorferi beta3-chain integrin ligand identified using a phage display library. Mol Microbiol (1999) 1.82

Identification of a candidate glycosaminoglycan-binding adhesin of the Lyme disease spirochete Borrelia burgdorferi. Mol Microbiol (2000) 1.81

Diverse Lyme disease spirochetes bind integrin alpha IIb beta 3 on human platelets. Infect Immun (1994) 1.71

Integrins alpha(v)beta3 and alpha5beta1 mediate attachment of lyme disease spirochetes to human cells. Infect Immun (1998) 1.68

Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J Biol Chem (1996) 1.67

Genetic control of experimental lyme arthritis in the absence of specific immunity. Infect Immun (1999) 1.40

Effects of Ixodes scapularis and Borrelia burgdorferi on modulation of the host immune response: induction of a TH2 cytokine response in Lyme disease-susceptible (C3H/HeJ) mice but not in disease-resistant (BALB/c) mice. Infect Immun (1997) 1.27

Invasion of human skin fibroblasts by the Lyme disease spirochete, Borrelia burgdorferi. J Infect Dis (1993) 1.25

The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J Immunol (1992) 1.16

Influence of decorin on fibroblast adhesion to fibronectin. Eur J Cell Biol (1991) 1.16

Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur J Cell Biol (1992) 1.13

Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J Immunol (1998) 1.08

Suppression of acute Ixodes scapularis-induced Borrelia burgdorferi infection using tumor necrosis factor-alpha, interleukin-2, and interferon-gamma. J Infect Dis (1996) 1.03

Variable small protein (Vsp)-dependent and Vsp-independent pathways for glycosaminoglycan recognition by relapsing fever spirochaetes. Mol Microbiol (2000) 1.02

Transforming growth factor-beta 1 induces extracellular matrix formation in glomerulonephritis. Cell Differ Dev (1990) 1.01

Integrin CR3 mediates the binding of nonspecifically opsonized Borrelia burgdorferi to human phagocytes and mammalian cells. Infect Immun (1997) 0.99

Erythema chronicum migrans: an electron-microscopic study. Dermatology (1993) 0.96

Failure of tetracycline therapy in early Lyme disease. Arthritis Rheum (1987) 0.96

Non-uniform influence of transforming growth factor-beta on the biosynthesis of different forms of small chondroitin sulphate/dermatan sulphate proteoglycan. Biochem J (1990) 0.91

Specific Th1 cell lines that confer protective immunity against experimental Borrelia burgdorferi infection in mice. J Leukoc Biol (1998) 0.85

Effects of bone morphogenetic protein-2 and transforming growth factor-beta1 on gene expression of decorin and biglycan by cultured osteoblastic cells. Histochem J (1999) 0.81

Articles by these authors

Formation of pluripotent stem cells in the mammalian embryo depends on the POU transcription factor Oct4. Cell (1998) 19.05

Quantification of low-copy transcripts by continuous SYBR Green I monitoring during amplification. Biotechniques (1998) 11.39

Explaining variation in general practitioner referrals to hospital. Fam Pract (1987) 10.27

Induction of an outer surface protein on Borrelia burgdorferi during tick feeding. Proc Natl Acad Sci U S A (1995) 9.93

Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev (1998) 8.51

Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates, and changed sexual behaviour in homosexual men in London. Lancet (1987) 7.71

MSCRAMM-mediated adherence of microorganisms to host tissues. Annu Rev Microbiol (1994) 7.14

Surface protein adhesins of Staphylococcus aureus. Trends Microbiol (1998) 6.86

Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol (2000) 6.68

Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci U S A (1984) 6.62

Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol (1997) 6.42

Altered immune responses in mice lacking inducible nitric oxide synthase. Nature (1995) 6.20

Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study. Lancet (2000) 5.93

Assessing completeness of cancer registration in the north-western region of England by a method of independent comparison. Br J Cancer (1982) 4.90

14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet (1999) 4.80

Relation of particle dimension to carcinogenicity in amphibole asbestoses and other fibrous minerals. J Natl Cancer Inst (1981) 4.60

Glycosaminoglycans and their binding to biological macromolecules. Annu Rev Biochem (1978) 4.51

Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn (2010) 4.48

Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc Natl Acad Sci U S A (1994) 4.44

Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet (1998) 4.44

The tetrodotoxin-resistant sodium channel SNS has a specialized function in pain pathways. Nat Neurosci (1999) 4.35

Smoking habits of oral contraceptive users. Lancet (1969) 4.20

Suppression of SHP-2 and ERK signalling promotes self-renewal of mouse embryonic stem cells. Dev Biol (1999) 4.00

Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med (2001) 3.98

Nucleotide sequence of the gene for a fibronectin-binding protein from Staphylococcus aureus: use of this peptide sequence in the synthesis of biologically active peptides. Proc Natl Acad Sci U S A (1989) 3.94

Detection in life of confirmed Alzheimer's disease using a simple measurement of medial temporal lobe atrophy by computed tomography. Lancet (1992) 3.94

Defective thymocyte maturation in p44 MAP kinase (Erk 1) knockout mice. Science (1999) 3.85

Cutting edge: inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol (1999) 3.80

Clumping factor B (ClfB), a new surface-located fibrinogen-binding adhesin of Staphylococcus aureus. Mol Microbiol (1998) 3.79

Cell-surface glycosaminoglycans. Annu Rev Biochem (1984) 3.68

Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect Immun (2001) 3.55

Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J (1986) 3.54

Campylobacter pyloridis in peptic ulcer disease: microbiology, pathology, and scanning electron microscopy. Gut (1985) 3.48

Identification of the NH2-terminal blocking group of calcineurin B as myristic acid. FEBS Lett (1982) 3.42

Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi vlsE. J Clin Microbiol (1999) 3.41

Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27

Molecular characterization and expression of a gene encoding a Staphylococcus aureus collagen adhesin. J Biol Chem (1992) 2.99

Adherence of Borrelia burgdorferi to the proteoglycan decorin. Infect Immun (1995) 2.96

Acceptors and rejectors of an invitation to undergo breast screening compared with those who referred themselves. J Epidemiol Community Health (1980) 2.95

Isolation and characterization of a fibronectin receptor from Staphylococcus aureus. J Biol Chem (1987) 2.91

The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem (1996) 2.88

Decorin-binding adhesins from Borrelia burgdorferi. Mol Microbiol (1998) 2.85

Amblyomma americanum: a potential vector of human ehrlichiosis. Am J Trop Med Hyg (1993) 2.84

Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus. Microbiology (1998) 2.82

Heritable susceptibility to severe Borrelia burgdorferi-induced arthritis is dominant and is associated with persistence of large numbers of spirochetes in tissues. Infect Immun (1994) 2.81

Cloning and expression of the gene for a fibronectin-binding protein from Staphylococcus aureus. EMBO J (1987) 2.79

Caesarean scar pregnancy. BJOG (2007) 2.77

The PRaCTICaL study of nurse led, intensive care follow-up programmes for improving long term outcomes from critical illness: a pragmatic randomised controlled trial. BMJ (2009) 2.74

Predicting successful vaginal birth after Cesarean section using a model based on Cesarean scar features examined by transvaginal sonography. Ultrasound Obstet Gynecol (2013) 2.73

The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83. Virology (1989) 2.72

Does it matter where you live? Treatment variation for breast cancer in Yorkshire. The Yorkshire Breast Cancer Group. Br J Cancer (1995) 2.71

Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes. Proc Natl Acad Sci U S A (1984) 2.71

Audit commission tackles anaesthetic services. BMJ (1998) 2.70

Contrast extravasation on CT predicts mortality in primary intracerebral hemorrhage. AJNR Am J Neuroradiol (2007) 2.69

Identification of a 47 kDa fibronectin-binding protein expressed by Borrelia burgdorferi isolate B31. Mol Microbiol (1998) 2.68

Delay in breast cancer and the nature of presenting symptoms. Lancet (1981) 2.67

Cell-surface heparan sulfate: an intercalated membrane proteoglycan. Proc Natl Acad Sci U S A (1981) 2.60

Thrombospondin modulates focal adhesions in endothelial cells. J Cell Biol (1989) 2.58

A radiation hybrid map of the rat genome containing 5,255 markers. Nat Genet (1999) 2.54

Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol. Gastroenterology (1997) 2.54

Exhaled breath condensate pH is a robust and reproducible assay of airway acidity. Eur Respir J (2003) 2.51

Colorectal hyperplasia and inflammation in keratin 8-deficient FVB/N mice. Genes Dev (1994) 2.51

The effect of adjunctive fresh frozen plasma administration on coagulation parameters and survival in a canine model of antivenom-treated brown snake envenoming. Anaesth Intensive Care (2005) 2.49

Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect Immun (1996) 2.49

Prospective randomized clinical trial of the value of intraperitoneal drainage after pancreatic resection. Ann Surg (2001) 2.47

Oral contraceptives and venous thromboembolism: findings in a large prospective study. Br Med J (Clin Res Ed) (1986) 2.47

A national health service and the public health. Public Health (1988) 2.46

The Staphylococcus aureus collagen adhesin is a virulence determinant in experimental septic arthritis. Infect Immun (1994) 2.44

On-site HIV testing in resource-poor settings: is one rapid test enough? AIDS (1997) 2.39

Rapid and sensitive quantification of Borrelia burgdorferi-infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol (1999) 2.39

Comparison of touch imprints with aspirate smears for evaluating bone marrow specimens. Am J Clin Pathol (1999) 2.38

Randomised controlled trial of self management leaflets and booklets for minor illness provided by post. BMJ (2001) 2.35

Microchimerism of maternal origin persists into adult life. J Clin Invest (1999) 2.35

Anxiety disorders in cancer patients: their nature, associations, and relation to quality of life. J Clin Oncol (2002) 2.34

Anticoagulant activity of heparin: separation of high-activity and low-activity heparin species by affinity chromatography on immobilized antithrombin. FEBS Lett (1976) 2.34

Antimicrobial resistance: Antibiotics and consultant oral microbiologist posts. Br Dent J (2016) 2.32

Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect Immun (1998) 2.29

Recommendations for conducting the in vivo alkaline Comet assay. 4th International Comet Assay Workshop. Mutagenesis (2003) 2.29

Clinical pharmacology clinics in general practice. Br Med J (1977) 2.28

Acute encephalopathy coincident with seroconversion for anti-HTLV-III. Lancet (1985) 2.26

Binding of Escherichia coli to fibronectin. A mechanism of tissue adherence. J Biol Chem (1984) 2.26

Qualms about QALYs. Lancet (1987) 2.26

Substrate adhesion of rat hepatocytes: mechanism of attachment to collagen substrates. Cell (1981) 2.26

Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr Pulmonol (2001) 2.24

Role of fibronectin-binding MSCRAMMs in bacterial adherence and entry into mammalian cells. Matrix Biol (1999) 2.23

Structure of the pericellular matrix: association of heparan and chondroitin sulfates with fibronectin-procollagen fibers. Cell (1982) 2.20

Generation of purified neural precursors from embryonic stem cells by lineage selection. Curr Biol (1998) 2.20

Cell-density-dependent expression of Borrelia burgdorferi lipoproteins in vitro. Infect Immun (1997) 2.19

Isolation of the pericellular matrix of human fibroblast cultures. J Cell Biol (1979) 2.19

Fibronectin receptors from Staphylococcus aureus. J Biol Chem (1983) 2.19

A proteoglycan form of heparin and its degradation to single-chain molecules. J Biol Chem (1978) 2.18

Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties. Infect Immun (1993) 2.18

Increasing springtime ozone mixing ratios in the free troposphere over western North America. Nature (2010) 2.17

Childhood-onset schizophrenia. Progressive ventricular change during adolescence. Arch Gen Psychiatry (1997) 2.15

Cell-surface heparan sulfate. Isolation and characterization of a proteoglycan from rat liver membranes. J Biol Chem (1979) 2.15

Isolation of stable mouse cell lines that express cell surface and secreted forms of the vesicular stomatitis virus glycoprotein. J Cell Biol (1983) 2.14

Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology (1991) 2.13